Pictured: the FerroTrace magnetic nanoparticles and FerroMag magnetic probe.
Project Title: Improving Colorectal Cancer Outcomes with Hybrid Cancer Tracers
Ferronova, in collaboration with the University of Sydney, the University of South Australia, and Victoria University of New Zealand, have developed FerroTrace, a new super-paramagnetic iron-oxide nanoparticle (SPION) to improve staging and radiotherapy in colorectal cancer.
The spread of cancer to nearby lymph nodes is a critical prognostic indicator in cancer and informs adjuvant therapy. Micro-metastasis (<2mm) in lymph nodes are difficult to detect with medical imaging missing 90% and colorectal surgery/pathology missing up to 25%.
FerroTrace is designed to direct the surgeons to the correct lymph nodes to sample and enable pathology to perform a more detailed analysis.
The feasibility and accuracy of staging of a new hybrid version of FerroTrace will be investigated in colorectal cancer in a collaboration with the Ingham Institute.
BMTH Round: Three
State: South Australia
Project Partners: University of Sydney, University of South Australia & Ingham Institute
- MTPConnect Grant: $826,000
- Industry Contribution: $1,620,000
Duration: October 2020 - September 2022
Contact: Stewart Bartlett